{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:09:15Z","timestamp":1789042155689,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,4]],"date-time":"2027-08-04T00:00:00Z","timestamp":1817337600000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["23PRE1019901"],"award-info":[{"award-number":["23PRE1019901"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P50AA030407-5130"],"award-info":[{"award-number":["P50AA030407-5130"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA030793"],"award-info":[{"award-number":["AA030793"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.plefa.2026.102764","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:44:22Z","timestamp":1785512662000},"page":"102764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of cyclooxygenase-mediated eicosanoids in alcohol-associated liver disease"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6824-0877","authenticated-orcid":false,"given":"Weilun","family":"Ai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Saraswathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2026.102764_bib0001","series-title":"Global Status Report on Alcohol and Health and Treatment of Substance use Disorders","year":"2024"},{"key":"10.1016\/j.plefa.2026.102764_bib0002","series-title":"Alcohol and Public Health: Alcohol-Related Disease Impact. Annual Average for United States 2020\u20132021 Alcohol-Attributable Deaths due to Excessive Alcohol use, All Ages","year":"2024"},{"key":"10.1016\/j.plefa.2026.102764_bib0003","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated Liver Diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.plefa.2026.102764_bib0004","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.amepre.2015.05.031","article-title":"2010 National and State costs of excessive alcohol consumption","volume":"49","author":"Sacks","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.plefa.2026.102764_bib0005","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gutjnl-2019-319720","article-title":"Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting","volume":"69","author":"Avila","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.plefa.2026.102764_bib0006","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3748\/wjg.v24.i26.2785","article-title":"Liver transplantation and alcoholic liver disease: history, controversies, and considerations","volume":"24","author":"Marroni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.plefa.2026.102764_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Practice guideline committee of the American association for the study of liver D, practice parameters committee of the American college of G. Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.plefa.2026.102764_bib0008","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Alcoholic Liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0009","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4947","article-title":"Role of 2\u2011series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non\u2011alcoholic fatty liver disease (Review)","volume":"47","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.plefa.2026.102764_bib0010","article-title":"Eicosanoids: atherosclerosis and cardiometabolic health","volume":"19","author":"Piper","year":"2020","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"10.1016\/j.plefa.2026.102764_bib0011","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.plefa.2026.102764_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111910","article-title":"Plasma phospholipid arachidonic acid in relation to non-alcoholic fatty liver disease: mendelian randomization study","volume":"106","author":"Chen","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.plefa.2026.102764_bib0013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajpath.2024.11.011","article-title":"An update on animal models of alcohol-associated liver disease","volume":"196","author":"Cao","year":"2026","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.plefa.2026.102764_bib0014","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1194\/jlr.R119000547","article-title":"Alcohol effects on hepatic lipid metabolism","volume":"61","author":"Jeon","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1194\/jlr.M041863","article-title":"CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis","volume":"55","author":"Clugston","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0016","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2006.05.009","article-title":"Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model","volume":"45","author":"Ji","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plefa.2026.102764_bib0017","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11010-011-1022-z","article-title":"Chronic alcohol intake-induced oxidative stress and apoptosis: role of CYP2E1 and calpain-1 in alcoholic cardiomyopathy","volume":"359","author":"Jing","year":"2012","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.plefa.2026.102764_bib0018","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.3390\/ijms22158221","article-title":"CYP2E1 in alcoholic and non-alcoholic liver injury. Roles of ROS, reactive intermediates and lipid overload","volume":"22","author":"Harjumaki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plefa.2026.102764_bib0019","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4331\/wjbc.v4.i4.119","article-title":"Effect of alcohol exposure on hepatic superoxide generation and hepcidin expression","volume":"4","author":"Harrison-Findik","year":"2013","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.plefa.2026.102764_bib0020","first-page":"899","article-title":"Copper\/zinc and manganese superoxide dismutases in alcoholic liver disease: immunohistochemical quantitation","volume":"11","author":"Zhao","year":"1996","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.plefa.2026.102764_bib0021","doi-asserted-by":"crossref","first-page":"G428","DOI":"10.1152\/ajpgi.00217.2019","article-title":"Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver","volume":"318","author":"Gopal","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"10.1016\/j.plefa.2026.102764_bib0022","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3748\/wjg.v16.i11.1304","article-title":"Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development","volume":"16","author":"Wang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.plefa.2026.102764_bib0023","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2018.00081","article-title":"Alcohol-mediated organ damages: heart and brain","volume":"9","author":"Obad","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102764_bib0024","first-page":"300","article-title":"Endotoxin and kupffer cell activation in alcoholic liver disease","volume":"27","author":"Wheeler","year":"2003","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.plefa.2026.102764_bib0025","article-title":"Prognostic value of neutrophil-lymphocyte ratio in patients with severe alcoholic Hepatitis","volume":"11","author":"Abu Omar","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.plefa.2026.102764_bib0026","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhep.2022.08.029","article-title":"Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis","volume":"78","author":"Cho","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plefa.2026.102764_bib0027","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4161\/oxim.3.3.12288","article-title":"Acetaldehyde adducts in alcoholic liver disease","volume":"3","author":"Setshedi","year":"2010","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.plefa.2026.102764_bib0028","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hep.27036","article-title":"Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice","volume":"60","author":"Kwon","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.plefa.2026.102764_bib0029","doi-asserted-by":"crossref","first-page":"25974","DOI":"10.1073\/pnas.1908137116","article-title":"Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking","volume":"116","author":"Guillot","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plefa.2026.102764_bib0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00432-003-0439-5","article-title":"Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma","volume":"129","author":"Munaka","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.plefa.2026.102764_bib0031","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2019.06.018","article-title":"ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles","volume":"71","author":"Seo","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plefa.2026.102764_bib0032","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jhep.2018.12.003","article-title":"Fibrosis and alcohol-related liver disease","volume":"70","author":"Lackner","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plefa.2026.102764_bib0033","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.plefa.2026.102764_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114732","article-title":"Role of eicosanoids in liver repair, regeneration and cancer","volume":"192","author":"Alvarez","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102764_bib0035","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.3748\/wjg.v23.i20.3572","article-title":"Cyclooxygenase 2 in liver dysfunction and carcinogenesis: facts and perspectives","volume":"23","author":"Martin-Sanz","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.plefa.2026.102764_bib0036","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jcp.2003.012120","article-title":"Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis","volume":"57","author":"Mohammed","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.plefa.2026.102764_bib0037","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1038\/onc.2017.73","article-title":"Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.plefa.2026.102764_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100823","article-title":"Global deletion of COX-2 attenuates hepatic inflammation but impairs metabolic homeostasis in diet-induced obesity","volume":"66","author":"Balakrishnan","year":"2025","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0039","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.plefa.2003.07.001","article-title":"Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases","volume":"69","author":"Hu","year":"2003","journal-title":"Prostaglandins Leukot Essent Fat. Acids"},{"key":"10.1016\/j.plefa.2026.102764_bib0040","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1872-034X.2008.00339.x","article-title":"Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts","volume":"38","author":"Kim","year":"2008","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0041","first-page":"1410","article-title":"Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398","volume":"7","author":"Bae","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0042","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1053\/gast.1997.v112.pm9041257","article-title":"Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat","volume":"112","author":"Nanji","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plefa.2026.102764_bib0043","doi-asserted-by":"crossref","first-page":"G100","DOI":"10.1152\/ajpgi.2000.279.1.G100","article-title":"Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver","volume":"279","author":"Enomoto","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"10.1016\/j.plefa.2026.102764_bib0044","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10787-006-1506-8","article-title":"Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats","volume":"14","author":"Bykov","year":"2006","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.plefa.2026.102764_bib0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.alcohol.2020.08.007","article-title":"Hepatic COX-2 expression protects mice from an alcohol-high fat diet-induced metabolic disorder by involving protein acetylation related energy metabolism","volume":"92","author":"Chen","year":"2021","journal-title":"Alcohol"},{"key":"10.1016\/j.plefa.2026.102764_bib0046","first-page":"57","article-title":"Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract","author":"Konturek","year":"2005","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102764_bib0047","doi-asserted-by":"crossref","first-page":"16496","DOI":"10.1016\/S0021-9258(19)84733-6","article-title":"Purification of the thromboxane A2\/prostaglandin H2 receptor from human blood platelets","volume":"264","author":"Ushikubi","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2026.102764_bib0048","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.plefa.2026.102764_bib0049","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-5793(82)81234-9","article-title":"Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape-change and secretion","volume":"148","author":"Rink","year":"1982","journal-title":"FEBS Lett."},{"key":"10.1016\/j.plefa.2026.102764_bib0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/ATVBAHA.121.317380","article-title":"A thromboxane A(2) receptor-driven COX-2-dependent feedback loop that affects endothelial homeostasis and angiogenesis","volume":"42","author":"Eckenstaler","year":"2022","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"10.1016\/j.plefa.2026.102764_bib0051","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archsurg.140.8.801","article-title":"Role of thromboxane in producing hepatic injury during hepatic stress","volume":"140","author":"Yokoyama","year":"2005","journal-title":"Arch. Surg."},{"key":"10.1016\/j.plefa.2026.102764_bib0052","doi-asserted-by":"crossref","first-page":"G453","DOI":"10.1152\/ajpgi.00315.2002","article-title":"Role of thromboxane A2 in early BDL-induced portal hypertension","volume":"284","author":"Yokoyama","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.plefa.2026.102764_bib0053","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00005344-198605000-00012","article-title":"Improvement in organ blood flow by inhibition of thromboxane synthetase during experimental endotoxic shock in the rat","volume":"8","author":"Tempel","year":"1986","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102764_bib0054","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hep.20000","article-title":"Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice","volume":"39","author":"Katagiri","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.plefa.2026.102764_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jhep.2007.03.019","article-title":"Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2)","volume":"47","author":"Steib","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plefa.2026.102764_bib0056","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bph.16238","article-title":"Thromboxane A2\/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non-alcoholic fatty liver disease","volume":"181","author":"Dai","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102764_bib0057","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/jama.2024.1215","article-title":"Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: a randomized clinical trial","volume":"331","author":"Simon","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.plefa.2026.102764_bib0058","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40262-021-01090-2","article-title":"Pharmacokinetic and pharmacodynamic profile of a novel phospholipid aspirin formulation","volume":"61","author":"Angiolillo","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.plefa.2026.102764_bib0059","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0262-1746(83)80002-X","article-title":"Raised plasma thromboxane B2 levels in alcoholic liver disease","volume":"10","author":"Ouwendijk","year":"1983","journal-title":"Prostaglandins. Leukot. Med."},{"key":"10.1016\/j.plefa.2026.102764_bib0060","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/acer.15391","article-title":"Blockade of thromboxane A2 signaling attenuates ethanol-induced myocardial inflammatory response in mice","volume":"48","author":"Ai","year":"2024","journal-title":"Alcohol Clin. Exp. Res. (Hob.)"},{"key":"10.1016\/j.plefa.2026.102764_bib0061","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0016-5085(97)70236-1","article-title":"Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat","volume":"112","author":"Nanji","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plefa.2026.102764_bib0062","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-3565(24)36899-5","article-title":"Alterations in thromboxane synthase and thromboxane A2 receptors in experimental alcoholic liver disease","volume":"282","author":"Nanji","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plefa.2026.102764_bib0063","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1530-0277.2012.01838.x","article-title":"Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations","volume":"37","author":"Nanji","year":"2013","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0064","article-title":"Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis","volume":"99","author":"Shin","year":"2020","journal-title":"Med. (Baltim.)"},{"key":"10.1016\/j.plefa.2026.102764_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115465","article-title":"Thromboxane A(2)-TP axis promotes adipose tissue macrophages M1 polarization leading to insulin resistance in obesity","volume":"210","author":"Xu","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102764_bib0066","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCRESAHA.125.325492","article-title":"Decoding the liver-heart axis in cardiometabolic diseases","volume":"136","author":"Capone","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0067","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/labinvest.3700712","article-title":"F2-isoprostane receptors on hepatic stellate cells","volume":"88","author":"Gardi","year":"2008","journal-title":"Lab. Invest."},{"key":"10.1016\/j.plefa.2026.102764_bib0068","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","article-title":"Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases","volume":"119","author":"Park","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.plefa.2026.102764_bib0069","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2018.02.009","article-title":"Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice","volume":"69","author":"Nishizawa","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plefa.2026.102764_bib0070","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.4049\/jimmunol.164.12.6467","article-title":"EBV suppresses prostaglandin E2 biosynthesis in human monocytes","volume":"164","author":"Savard","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.plefa.2026.102764_bib0071","doi-asserted-by":"crossref","first-page":"17315","DOI":"10.1073\/pnas.1008209107","article-title":"PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury","volume":"107","author":"North","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plefa.2026.102764_bib0072","doi-asserted-by":"crossref","first-page":"G1071","DOI":"10.1152\/ajpgi.00327.2015","article-title":"Microsomal prostaglandin E synthase-1 protects against Fas-induced liver injury","volume":"310","author":"Yao","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.plefa.2026.102764_bib0073","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34633-y","article-title":"Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model","volume":"8","author":"Henkel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.plefa.2026.102764_bib0074","first-page":"367","article-title":"Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2","volume":"142","author":"Nanji","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.plefa.2026.102764_bib0075","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/gut.30.9.1270","article-title":"Prostaglandin E2 and leukotriene B4 synthesis by peripheral leucocytes in alcoholics","volume":"30","author":"Maxwell","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.plefa.2026.102764_bib0076","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1194\/jlr.M066175","article-title":"Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese","volume":"57","author":"Puri","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0077","first-page":"G574","article-title":"Kupffer cell prostaglandin E2 stimulates parenchymal cell O2 consumption: alcohol and cell-cell communication","volume":"270","author":"Qu","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.plefa.2026.102764_bib0078","doi-asserted-by":"crossref","first-page":"123S","DOI":"10.1097\/01.ALC.0000133541.13670.58","article-title":"Effect of prostaglandin E receptor subtype EP4 selective agonist on the secretion of tumor necrosis factor-alpha by macrophages in acute ethanol-loaded rats","volume":"28","author":"Nakatani","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0079","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.23009","article-title":"Endotoxemia and gut barrier dysfunction in alcoholic liver disease","volume":"50","author":"Rao","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.plefa.2026.102764_bib0080","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1830693","article-title":"Therapeutic manipulation of gut microbiota by polysaccharides of Wolfiporia cocos reveals the contribution of the gut fungi-induced PGE(2) to alcoholic hepatic steatosis","volume":"12","author":"Sun","year":"2020","journal-title":"Gut. Microbes."},{"key":"10.1016\/j.plefa.2026.102764_bib0081","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2501902122","article-title":"Molecular basis for ligand recognition and receptor activation of the prostaglandin D2 receptor DP1","volume":"122","author":"Xu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plefa.2026.102764_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106429","article-title":"Lipocalin-type prostaglandin D(2) synthase deletion induces dyslipidemia and non-alcoholic fatty liver disease","volume":"149","author":"Kumar","year":"2020","journal-title":"Prostaglandins. Other Lipid Mediat."},{"key":"10.1016\/j.plefa.2026.102764_bib0083","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/hep.28442","article-title":"Shutting off inflammation: a novel switch on hepatic stellate cells","volume":"63","author":"Cubero","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.plefa.2026.102764_bib0084","article-title":"Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.plefa.2026.102764_bib0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0955-2863(00)00112-1","article-title":"Changes in the prostaglandin levels in alcohol toxicity: effect of curcumin and N-acetylcysteine","volume":"11","author":"Rajakrishnan","year":"2000","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.plefa.2026.102764_bib0086","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/HEP.0000000000001020","article-title":"PGD 2 \/DP1 axis promotes liver regeneration by secreting Wnt2 in KCs in mice","volume":"82","author":"Li","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.plefa.2026.102764_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.1998.13.1.1","article-title":"Effects of prostaglandins on ethanol damage in primary cultured rat hepatocytes","volume":"13","author":"Yang","year":"1998","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.plefa.2026.102764_bib0088","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1590\/S0102-86502009000300012","article-title":"Iloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemia-reperfusion in rats","volume":"24","author":"Gedik","year":"2009","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.plefa.2026.102764_bib0089","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-0012.2000.140113.x","article-title":"Administration of prostacyclin after liver transplantation: a placebo controlled randomized trial","volume":"14","author":"Neumann","year":"2000","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.plefa.2026.102764_bib0090","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1600-6143.2011.03568.x","article-title":"Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation","volume":"11","author":"Ghonem","year":"2011","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.plefa.2026.102764_bib0091","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0024-3205(94)00404-8","article-title":"Decreased prostacyclin production by liver non-parenchymal cells precedes liver injury in experimental alcoholic liver disease","volume":"54","author":"Nanji","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.plefa.2026.102764_bib0092","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s41374-021-00531-7","article-title":"Alternative activation of macrophages by prostacyclin synthase ameliorates alcohol induced liver injury","volume":"101","author":"Pan","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.plefa.2026.102764_bib0093","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.prostaglandins.2015.04.006","article-title":"Prostacyclin protects vascular integrity via PPAR\/14-3-3 pathway","volume":"118-119","author":"Chu","year":"2015","journal-title":"Prostaglandins. Other Lipid Mediat."},{"key":"10.1016\/j.plefa.2026.102764_bib0094","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-3565(25)22707-0","article-title":"Acute and chronic effects of ethanol and its metabolites on vascular production of prostacyclin in rats","volume":"240","author":"Guivernau","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plefa.2026.102764_bib0095","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.7754\/Clin.Lab.2014.140405","article-title":"Prostaglandin F2 alpha plasma concentration predicts glycemic control and oxidation status in patients with type 2 diabetes mellitus","volume":"60","author":"Nakhjavani","year":"2014","journal-title":"Clin. Lab."},{"key":"10.1016\/j.plefa.2026.102764_bib0096","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2337\/db17-1521","article-title":"Prostaglandin F(2alpha) facilitates hepatic glucose production through CaMKIIgamma\/p38\/FOXO1 signaling pathway in fasting and obesity","volume":"67","author":"Wang","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2026.102764_bib0097","first-page":"327","article-title":"Prostaglandin synthesis and response to alcoholism treatment","volume":"22","author":"MacMurray","year":"1987","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.plefa.2026.102764_bib0098","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1530-0277.1984.tb05847.x","article-title":"Effects of chronic ethanol treatment on lipid composition and prostaglandins in rats fed essential fatty acid deficient diets","volume":"8","author":"Alling","year":"1984","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.plefa.2026.102764_bib0099","doi-asserted-by":"crossref","first-page":"15197","DOI":"10.1096\/fj.202001481R","article-title":"Prostaglandin F(2alpha) receptor antagonist attenuates LPS-induced systemic inflammatory response in mice","volume":"34","author":"Maehara","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.plefa.2026.102764_bib0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00109-013-1119-9","article-title":"FP-receptor gene silencing ameliorates myocardial fibrosis and protects from diabetic cardiomyopathy","volume":"92","author":"Ding","year":"2014","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.plefa.2026.102764_bib0101","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/VHRM.S2477","article-title":"Treprostinil for pulmonary hypertension","volume":"4","author":"Skoro-Sajer","year":"2008","journal-title":"Vasc. Health Risk. Manage"},{"key":"10.1016\/j.plefa.2026.102764_bib0102","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011902","article-title":"Antagonism of the thromboxane-prostanoid receptor as a potential therapy for cardiomyopathy of muscular dystrophy","volume":"8","author":"West","year":"2019","journal-title":"J. Am. Heart. Assoc."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:19:41Z","timestamp":1789039181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327826000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":102,"alternative-id":["S0952327826000426"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102764","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cyclooxygenase-mediated eicosanoids in alcohol-associated liver disease","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102764"}}